GovChime
PIID: SPE2DP26F0985AWARDDELIVERY ORDERSmall Business

Delivery order SPE2DP26F0985TEVA PHARMACEUTICALS USA, INC.

Overview

Award facts

Net obligations: $330,314

Type
Delivery order
PIID
SPE2DP26F0985
Awarded by
Department of Defense › Defense Logistics Agency › DLA TROOP SUPPORT
Recipient
TEVA PHARMACEUTICALS USA, INC. (UEI NEN9A34LRHJ5)NORTH WALES, PA
Product or service (PSC)
6505 — DRUGS AND BIOLOGICALS
Date
Signed on Dec 1, 2025
Period of performance
Dec 1, 2025 to Dec 9, 2025 (potential end Dec 8, 2025)
Options
Base and all options value: $330,314
Extent competed
NOT COMPETED
Solicitation procedures
ONLY ONE SOURCE
Set-aside
No set-aside reported
Contract pricing
FIRM FIXED PRICE
Place of performance
PARSIPPANY, NJ
Ordered under
IDV SPE2DP20D0002 (523 orders recorded under it)
Modifications
0; latest action Dec 1, 2025
Obligations by fiscal year of action
  • FY2026: $330,314

Description

8511784115!ADENOVIRUS TYPE 4 A

The Department of Defense funded and awarded this contract. DoD contract actions are withheld at the source for about 90 days after signature, so actions signed after Jul 16, 2026 are not yet public.

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Dec 1, 2025. View on USAspending · Recipient on SAM.gov

Awardee

UEINEN9A34LRHJ5
CAGE code3V8D7
Business sizeOTHER THAN SMALL BUSINESS

Transaction history

Transaction history

Every modification of this award, with its obligation change and reason.